Genus (GNS)

Sector:

Pharma and Biotech

Index:

FTSE 250

   Trade now with Barclays Stockbrokers   Trade now with Barclays   Sponsored by Barclays Stockbrokers

2,608.00p
   
  • Change Today:
    -12.00p
  • 52 Week High: 2,992.00
  • 52 Week Low: 2,098.00
  • Currency: UK Pounds
  • Shares Issued: 65.05m
  • Volume: 492,097
  • Market Cap: £1,696.55m
  • RiskGrade: 174
  • Beta: 0.00

Broker List

Order by
Date Broker name New Price Old price target New price target Broker change
28-Feb-19 Liberum Capital Hold 2,190.00p - 2,400.00p Reiteration
06-Dec-18 Kepler Capital Markets Buy 2,386.00p 2,475.00p 2,630.00p Upgrade
06-Sep-18 Peel Hunt Limited Hold 2,542.00p - 2,600.00p DownGrade
01-Mar-18 Berenberg Bank Hold 2,200.00p 1,800.00p 1,800.00p Reiteration
30-Oct-17 N 1 Singer Buy 2,430.00p 1,844.00p 2,485.00p Upgrade
04-Aug-16 HSBC Buy 1,907.00p - 2,200.00p Reiteration
12-May-15 Numis Securities Hold 1,388.00p - 1,410.00p Reiteration
01-Apr-14 Panmure Gordon Sell 985.50p 1,055.00p 910.00p Reiteration
25-Jun-13 Nplus1 Brewin Hold 1,305.00p 1,348.00p 1,348.00p Upgrade
30-Apr-13 Shore Capital Sell 1,355.00p - - Reiteration
20-Mar-13 Morgan Stanley Overweight 1,574.00p 1,360.00p 1,740.00p Reiteration

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

Note 3: Consensus broker estimates sourced from FactSet Research Systems Inc., who calculate consensus using only those estimates changed or actively validated within the last 75 days.

 

Genus Market Data

Currency UK Pounds
Share Price 2,608.00p
Change Today -12.00p
% Change -0.46 %
52 Week High 2,992.00
52 Week Low 2,098.00
Volume 492,097
Shares Issued 65.05m
Market Cap £1,696.55m
Beta 0.00
RiskGrade 174

Genus Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
95.62% below the market average95.62% below the market average95.62% below the market average95.62% below the market average95.62% below the market average
89.66% below the sector average89.66% below the sector average89.66% below the sector average89.66% below the sector average89.66% below the sector average
Price Trend
70.41% above the market average70.41% above the market average70.41% above the market average70.41% above the market average70.41% above the market average
57.38% above the sector average57.38% above the sector average57.38% above the sector average57.38% above the sector average57.38% above the sector average
Income
91.64% below the market average91.64% below the market average91.64% below the market average91.64% below the market average91.64% below the market average
69.23% below the sector average69.23% below the sector average69.23% below the sector average69.23% below the sector average69.23% below the sector average
Growth
71.18% below the market average71.18% below the market average71.18% below the market average71.18% below the market average71.18% below the market average
94.74% below the sector average94.74% below the sector average94.74% below the sector average94.74% below the sector average94.74% below the sector average

What The Brokers Say

Strong Buy 3
Buy 0
Neutral 2
Sell 0
Strong Sell 0
Total 5
buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

Genus Dividends

  Latest Previous
  Interim Final
Ex-Div 07-Mar-19 15-Nov-18
Paid 04-Apr-19 30-Nov-18
Amount 8.90p 17.90p

Trades for 14-Jun-2019

Time Volume / Share Price
16:35 9,672 @ 2,608.00p
16:29 16 @ 2,608.00p
16:26 92 @ 2,610.00p
16:26 40 @ 2,610.00p
16:26 47 @ 2,610.00p

Genus Key Personnel

Chair Robert (Bob) Lawson
CEO Karim Bitar

Top of Page